Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
143B |
Human osteosarcoma cell line | ATCC CRL-8303 | Human | bone | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | A. D’Angelo, Dissertation, University of Parma | Link | |
293L |
Human embryonic kidney cell line (derivat of HEK293) | Human | urinary system | cell line | adherent | bacmid | stable transfection | Metafectene PRO | publication | P. Dabral et al., J. of Virology, 2019, 93: e02256-18, doi.org/10.1128/JVI.02256-18 | Link | ||
293L |
Human embryonic kidney cell line (derivat of HEK293) | Human | urinary system | cell line | adherent | bacmid | stable transfection | Metafectene PRO | publication | T. Uppal et al., J. of Virology, 2019, 93, 8 e01983-18, doi.org/10.1128/JVI.01983-18 | Link | ||
293L |
Human embryonic kidney cell line (derivat of HEK293) | Human | urinary system | cell line | adherent | bacmid | stable transfection | Metafectene PRO | publication | P. Dabral, Dissertation, 2019, University of Nevada | Link | ||
293L |
Human embryonic kidney cell line (derivat of HEK293) | Human | urinary system | cell line | adherent | bacmid | stable transfection | Metafectene PRO | publication | M. E. McDowell, Dissertation, 2012, University of Nevada | Link | ||
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | stable transfection | K2 Transfection System | publication | C. I. McCarthy et al., J. Gen. Physiol., 2020, 152, 5: e201912492, doi.org/10.1085/jgp.201912492 | Link | |
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | suspension | plasmid | stable transfection | Metafectene EASY | publication | M. E. Madlener, 2012, Dissertation, Universität zu Köln | Link | |
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | stable transfection | K2 Transfection System | publication | E. Echeverría et al., Front. Pharmacol., 2020, 11: 113, doi: 10.3389/fphar.2020.00113 | Link | |
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | stable transfection | K2 Transfection System | publication | A. Rodrıguez Gonzalez et al., The FEBS J., 2020, 288:229–243, doi:10.1111/febs.15344 | ||
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene | publication | B. C. Viertlboeck et al., J. Immunol., Jun 2009; 182: 6985 - 6992 | Link | |
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene | publication | S. M. Hoser et al., Genome Biology, 2020, 21: 299, doi.org/10.1186/s13059-020-02199-6 | Link | |
A-2780 |
Human ovarian carcinoma cell line | Human | genital tract | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | C.F.T. Taute, PhD Thesis, 2013, University of the Western Cape | Link | ||
A375 |
Human skin malignant melanoma cell line | ATCC CRL-1619 | Human | skin | cell line | adherent | plasmid | stable transfection | K2 Transfection System | publication | M. Tufano et al., Front. Cell Dev. Biol., 2021, 9: 718947, doi: 10.3389/fcell.2021.718947 | Link | |
A431 |
Human epidermoid carcinoma cell line | ATCC CRL-1555 | Human | skin | cell line | adherent | plasmid | stable transfection | Metafectene | publication | S. Rungaldier et al., PLOSONE, June 2017, https://doi.org/10.1371/journal.pone.0178646 | Link | |
A549 |
Human lung alveolar epithelial adenocarcinoma carcinoma cell line | ATCC CCL-185 | Human | respiratory system | cell line | adherent | plasmid | stable transfection | Metafectene | publication | F. Morsbach, Dissertation, 2013, University Medical Center Hamburg-Eppendorf | Link | |
A549 |
Human lung alveolar epithelial adenocarcinoma carcinoma cell line | ATCC CCL-185 | Human | respiratory system | cell line | adherent | plasmid | stable transfection | Metafectene | publication | F. Morsbach, Dissertation, 2013, University Medical Center Hamburg-Eppendorf | Link | |
AGS |
Human gastric adenocarcinoma cell line | ATCC CRL-1739 | Human | digestive organs | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | H. Jee, Dissertation, 2013, Seoul National University | Link | |
BxPC3 |
Human pancreatic adenocarcinoma cell line | ATCC CRL-1687 | Human | digestive organs | cell line | adherent | plasmid | stable transfection | K2 Transfection System | publication | A. Carozzoa et al., Mol. Pharmacology, 2019, 115444, DOI: 10.1124/mol.118.115444 | Link | |
C4-2 |
Human prostate carcinoma cell line (derivative of LNCaP) | Human | genital tract | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | R.C. Peery, Dissertation,, 2020, Indiana University | Link | ||
DLD-1 |
Human colon adenocarcinoma cell line | ATCC CCL-221 | Human | digestive organs | cell line | adherent | plasmid | stable transfection | Metafectene | publication | C. Emming, Dissertation, 2021, Ludwig-Maximilians-Universität München | Link | |
EFO-27 |
Human ovary adenocarcinoma cell line (cisplatin resistant) | Human | genital tract | cell line | adherent | plasmid | stable transfection | K2 Transfection System | application note | ![]() |
|||
Flp-In 293 |
Human embryonic kidney cell line (derivative of HEK293) | Human | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene | publication | S. M. Hoser et al., Genome Biology, 2020, 21: 299, doi.org/10.1186/s13059-020-02199-6 | Link | ||
Flp-In T-REx HeLa |
Human cervix adenocarcinoma cell line (derivative of HeLa) | Human | genital tract | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | T. M. Nthiga et al., J. Cell Biol., 2021, 220, 6, doi.org/10.1083/jcb.202006128 | Link | ||
Flp-in TREx 293 |
Human embryonic kidney cell line (derivative of HEK293) | Human | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | T. M. Nthiga et al., The EMBO J., 39: e103649, DOI 10.15252/embj.2019103649 | Link | ||
Flp-in TREx 293 |
Human embryonic kidney cell line (derivative of HEK293) | Human | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | B.K. Shrestha et al., J Biol Chem., 2020, 295(5): 1240–1260, doi: 10.1074/jbc.RA119.010068 | Link |